ARGENX SE is 2.9x more valuable than Moderna, Inc. by market capitalization ($53.35 B vs $18.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARGX | MRNA |
|---|---|---|
| Market cap | $53.35 B | $18.25 B |
| US-listed rank | #306 | #650 |
| Revenue (latest FY) | - | $1.94B |
| Net income (latest FY) | - | -$2.82B |
| Net margin | - | -145.2% |
| SEC filings | 272 | 1,447 |
ARGENX SE is 2.9x more valuable than Moderna, Inc. by market capitalization ($53.35 B vs $18.25 B).
Full pages: ARGENX SE and Moderna, Inc., or browse the full rankings.